$PPHM Income Statement

0
1428

Peregrine Pharmaceuticals, Inc. (PPHM)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Apr 30, 2015 Jan 31, 2015 Oct 31, 2014 Jul 31, 2014
Total Revenue 9,308   5,677   6,300   5,496  
Cost of Revenue 4,758 3,113 4,139 3,583
Gross Profit 4,550   2,564   2,161   1,913  
Operating Expenses
Research Development 11,531 11,261 10,003 10,201
Selling General and Administrative 5,188 4,325 4,295 4,883
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (12,169) (13,022) (12,137) (13,171)
Income from Continuing Operations
Total Other Income/Expenses Net 34 29 37 42
Earnings Before Interest And Taxes (12,135) (12,993) (12,100) (13,129)
Interest Expense 1
Income Before Tax (12,135) (12,994) (12,100) (13,129)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (12,135) (12,994) (12,100) (13,129)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (12,135) (12,994) (12,100) (13,129)
Preferred Stock And Other Adjustments (1,119) (775) (774) (1,028)
Net Income Applicable To Common Shares (13,254) (13,769) (12,874) (14,157)

LEAVE A REPLY

Please enter your comment!
Please enter your name here